Form 4: VSee Health CFO Acquires Shares, Ownership Shifts

VSee Health's Chief Financial Officer, Jerry Leonard, reported multiple acquisitions of common stock totaling 560,724 shares, including a retention bonus and compensation for past services.

Summary

• Jerry Leonard, CFO of VSEE HEALTH, INC., reported three acquisitions of common stock on September 19, 2025.
• Acquired 300,000 shares as a retention bonus under the issuer's 2024 Incentive Plan, with a price of $0 per share.
• Acquired 135,724 shares at $2.18 per share, in lieu of $295,880 of unpaid cash compensation for services rendered from 2022 to 2025.
• Acquired 125,000 shares as part of the 2024 Incentive Plan for services rendered to VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. prior to the June 2024 business combination, with a price of $0 per share.
• The total number of shares acquired across these reported transactions is 560,724.
• Following these reported transactions, the beneficial ownership of common stock by Jerry Leonard is stated as 125,000 shares.

Sentiment

Score: 6

Explanation: The acquisition of shares by a CFO is generally positive, indicating confidence and alignment. However, the ambiguity in the reported beneficial ownership figures and the issuance of shares for unpaid compensation introduce some uncertainty, preventing a higher score.

Positives

• CFO Jerry Leonard acquired a significant number of shares (560,724 total) through various grants and compensation, indicating alignment with shareholder interests.
• The issuance of 300,000 shares as a retention bonus suggests the company is incentivizing key management.
• Issuing 135,724 shares in lieu of $295,880 unpaid cash compensation helps conserve cash for the company.
• The grants for past services (125,000 shares) acknowledge contributions from prior entities now part of VSee Health.

Negatives

• The reported "Amount of Securities Beneficially Owned Following Reported Transaction(s)" decreases from 560,724 to 125,000 across the three acquisition entries, despite all transactions being explicitly reported as acquisitions ("A"). This creates significant ambiguity regarding the net change in total beneficial ownership, as the total shares acquired (560,724) is substantially higher than the final reported beneficial ownership (125,000).
• The issuance of shares in lieu of $295,880 unpaid cash compensation could indicate cash flow constraints for the company.

Risks

• Ambiguity in the reported beneficial ownership figures could lead to misinterpretation of the insider's true stake.
• Issuing shares for unpaid compensation might dilute existing shareholders if not managed effectively.
• The future value of the shares issued for compensation is subject to market fluctuations.

Future Outlook

The filing primarily reports past and current equity compensation events and does not provide explicit forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the implication of the 2024 Incentive Plan.

Management Comments

• Reflects shares of common stock granted to the reporting person as a retention bonus under the issuer's 2024 Incentive Plan.
• Reflects shares of common stock issued to the reporting person under the issuer's 2024 Incentive Plan in lieu of an aggregate of $295,880 of unpaid cash compensation that was owed by the issuer and its subsidiaries and predecessors to the reporting person for services rendered during the 2022, 2023, 2024 and 2025 fiscal years. The number of shares issued to the reporting person is based on a per share price of $2.18.
• Reflects shares of common stock granted to the reporting person under the issuer's 2024 Incentive Plan in connection with services rendered to VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. prior to the issuer's June 2024 business combination.

Industry Context

This Form 4 filing reflects standard practices in executive compensation, particularly in growth-oriented companies or those undergoing integration post-merger. Equity grants for retention and in lieu of cash compensation are common mechanisms to align management incentives with long-term company performance and manage cash flow, respectively. The reference to a 2024 Incentive Plan suggests a structured approach to employee and executive equity compensation, typical for publicly traded companies.

Comparison to Industry Standards

• Equity compensation, including retention bonuses and grants for past services, is a common practice across the technology and healthcare sectors, particularly for executives in companies like Teladoc Health or Amwell, to incentivize long-term commitment and performance.
• Issuing shares in lieu of cash compensation, as seen with $295,880 converted to 135,724 shares at $2.18, is a strategy often employed by companies, especially startups or those in growth phases, to preserve cash, similar to how many early-stage tech companies compensate key personnel.
• The use of a 2024 Incentive Plan aligns with corporate governance best practices for public companies to provide a framework for equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from new share issuances, but also increased management alignment. Ambiguity in total beneficial ownership could affect investor confidence.
• Employees: The 2024 Incentive Plan and retention bonus indicate a structured approach to incentivizing key personnel.
• Management (Jerry Leonard): Increased equity stake and compensation for past services.

Next Steps

• Monitor future Form 4 filings for Jerry Leonard to clarify the net change in beneficial ownership.
• Observe VSee Health's future financial reports for details on cash flow management and the impact of equity compensation plans.

Key Dates

Recommendation

While the CFO's acquisition of a substantial number of shares, including a retention bonus, generally signals confidence and aligns management interests with shareholders, the ambiguity surrounding the net change in total beneficial ownership after these transactions warrants caution. The issuance of shares in lieu of unpaid cash compensation could also suggest cash flow management considerations. Investors should hold and monitor subsequent filings for clarity on the CFO's total stake and the company's financial health before making further investment decisions.

Keywords

VSee Health, VSEE, Form 4, Insider Trading, Stock Acquisition, CFO, Jerry Leonard, Equity Compensation, Retention Bonus, Share Ownership